The United States Of America, As Represented By The Secretary, Department Of Health And Human Services competitive analysis

Explore The United States Of America, As Represented By The Secretary, Department Of Health And Human Services's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 5, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 31, 2025Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen7
Dec 27, 2023Method For Purifying Antibodies2
Jun 28, 2023Methods For Modulating Chemotherapeutic Cytotoxicity1
Feb 22, 2023Diagnostic Methods For T Cell Therapy1
Jan 25, 2023Photo-Controlled Removal Of Targets In Vitro And In Vivo1
Jun 19, 2019Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes1
Feb 13, 2019Radioprotectants Targeting Thrombospondin-1 And Cd471
Dec 19, 2018Photosensitizing Antibody-Fluorophore Conjugates1
Oct 17, 2018Complexes Of Il-15 And Il-15R Alpha And Uses Thereof1
Aug 17, 2016Method For On-Demand Contraception7

Latest PTAB cases involving The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

Discover the latest PTAB cases involving The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing The United States Of America, As Represented By The Secretary, Department Of Health And Human Services with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 5, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
THE UNITED STATES OF AMERICA - 44 - 1
BOULT WADE TENNANT62 - - -
EUSA PHARMA (UK) LIMITED1 - - -
STRAWMAN478 - - -